GL1X · GenesisL1 explorer

MolNFT v1 · #111325 · protein

Crystal structure of vitamin D receptor ligand binding domain complexed with a 19-norvitamin D compound

4YNK · Vitamin D3 RECEPTOR,VITAMIN D3 receptor: “Crystal structure of vitamin D receptor ligand binding domain complexed with a 19-norvitamin D compound”. X-ray diffraction, 1 ligand (YW2), 2 pockets (best druggability 0.87). MolNFT v1…

PDB
4YNK
Type
protein
Length
250 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Vitamin D3 RECEPTOR,VITAMIN D3 receptor; Coactivator peptide drip from cdna FLJ50196…
UniProt
P13053
Ligands
YW2
Pockets
2 · best druggability 0.87

Structure

x-ray diffraction · 2 distinct chains · 65% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVitamin D3 RECEPTOR,VITAMIN D3 receptorprotein24065% helix, 3% strandP13053
CCoactivator peptide drip from cdna FLJ50196, highly similar to peroxisome proliferator-activated receptor-binding proteinprotein1070% helix, 0% strand—

Ligands and binding sites

  • YW2 · (1R,3R,7E,17beta)-17-{(5S)-5-hydroxy-5-[(3R,5R,7R)-tricyclo[3.3.1.1~3,7~]dec-1-yl]penta-1,3-diyn-1-yl}-2-methylidene-9,10-secoestra-5,7-diene-1,3-diol · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13830.870.9541YW2
2630.280.7315empty

Interfaces

1 interface between chains.

  • A–C · 532 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 4YNK · Crystal structure of vitamin D receptor ligand binding domain complexed with a… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.